Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years
- PMID: 21792045
- DOI: 10.1097/MPH.0b013e31820e7361
Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years
Abstract
The outcome of childhood acute lymphoblastic leukemia in India has been inferior to more than 80% cure rates in developed nations. This study was done to analyze the outcome of acute lymphoblastic leukemia in India over 4 decades. There has been a gradual improvement in survival rates of up to >70% in some centers along with a decline in relapse and mortality. However, these results cannot be generalized to the entire nation. There is a crying need to address treatment abandonment, take quality improvement, educational and financial initiatives; cooperative research into risk factors and disease biology, and the implementation of risk stratification along with the assessment of response to therapy.
Comment in
-
Childhood acute lymphoblastic leukemia outcome in India: progress on all fronts.J Pediatr Hematol Oncol. 2012 May;34(4):324. doi: 10.1097/MPH.0b013e3182422ca0. J Pediatr Hematol Oncol. 2012. PMID: 22395214 No abstract available.
-
Outcome of acute lymphoblastic leukemia in India: the challenges ahead.J Pediatr Hematol Oncol. 2013 May;35(4):334. doi: 10.1097/MPH.0b013e3182706ebf. J Pediatr Hematol Oncol. 2013. PMID: 23042007 No abstract available.
Similar articles
-
Childhood acute lymphoblastic leukemia outcome in India: progress on all fronts.J Pediatr Hematol Oncol. 2012 May;34(4):324. doi: 10.1097/MPH.0b013e3182422ca0. J Pediatr Hematol Oncol. 2012. PMID: 22395214 No abstract available.
-
Outcome of acute lymphoblastic leukemia in India: the challenges ahead.J Pediatr Hematol Oncol. 2013 May;35(4):334. doi: 10.1097/MPH.0b013e3182706ebf. J Pediatr Hematol Oncol. 2013. PMID: 23042007 No abstract available.
-
Treating leukemia in a resource poor setting.Indian Pediatr. 2008 May;45(5):410-2. Indian Pediatr. 2008. PMID: 18515933
-
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].Eur J Cancer. 2005 Jul;41(11):1570-83. doi: 10.1016/j.ejca.2004.11.004. Epub 2005 Jan 5. Eur J Cancer. 2005. PMID: 16026693 Review.
-
Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.Pediatr Blood Cancer. 2009 May;52(5):559-65. doi: 10.1002/pbc.21889. Pediatr Blood Cancer. 2009. PMID: 19127567 Review.
Cited by
-
L-Asparaginase induced thrombosis in acute lymphoblastic leukemia.J Pharmacol Pharmacother. 2012 Jul;3(3):285-6. doi: 10.4103/0976-500X.99449. J Pharmacol Pharmacother. 2012. PMID: 23129971 Free PMC article. No abstract available.
-
Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?Eur J Clin Pharmacol. 2014 Mar;70(3):253-60. doi: 10.1007/s00228-013-1623-4. Epub 2013 Dec 27. Eur J Clin Pharmacol. 2014. PMID: 24370659 Review.
-
Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol.Indian J Med Paediatr Oncol. 2015 Oct-Dec;36(4):261-4. doi: 10.4103/0971-5851.171552. Indian J Med Paediatr Oncol. 2015. PMID: 26811597 Free PMC article.
-
Outcome of ALL With ALL-BFM-95 Protocol in Nepal.JCO Glob Oncol. 2023 Jun;9:e2200408. doi: 10.1200/GO.22.00408. JCO Glob Oncol. 2023. PMID: 37428991 Free PMC article.
-
Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey.PLoS One. 2016 Oct 13;11(10):e0163090. doi: 10.1371/journal.pone.0163090. eCollection 2016. PLoS One. 2016. PMID: 27736871 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources